The Emulation and Adaptation of a Global Model of Clinical Practice Guidelines on Chronic Heart Failure in BRICS

Tao Liu1,2,3,4, Benjamin Quasinowski2,3,4, André Soares2,3

  • 1School of Public Affairs, Zhejiang University, Hangzhou 310058, China.

Insights

Clinical practice guidelines for heart failure in BRICS nations largely mirror global models but show some adaptation. They rarely address country-specific healthcare costs or access issues.

Area of Science:

  • Global Health
  • Health Policy
  • Sociology of Health

Background:

  • Access to healthcare is uneven globally, particularly for non-communicable diseases in low- and middle-income countries (LMIC).
  • BRICS (Brazil, Russia, India, China, South Africa) nations are increasingly influential in global health, advocating for equitable healthcare access.
  • Non-communicable diseases disproportionately affect LMIC, with 80% of global deaths occurring in these regions.

Purpose of the Study:

  • To investigate the influence of global health scripts on heart failure guidelines in BRICS countries.
  • To analyze the convergence and divergence of these guidelines within the BRICS inter-state context.
  • To explore the adaptation of international cardiology models within BRICS healthcare systems.

Main Methods:

  • Content analysis of heart failure clinical practice guidelines published by BRICS countries.
  • Comparative analysis of guideline recommendations against established European and American cardiology standards.
  • Sociological interpretation using neoinstitutionalism and globalization theories.

Main Results:

  • BRICS heart failure guidelines predominantly adopt frameworks from European and American cardiology organizations.
  • Guidelines show some divergence, particularly concerning specific epidemiological conditions relevant to BRICS.
  • Most BRICS guidelines, except India's, minimally address cost, access, and affordability of care within their specific contexts.

Conclusions:

  • Clinical practice guidelines for heart failure in BRICS countries exhibit isomorphic diffusion, largely conforming to global standards.
  • Localized adaptation occurs, incorporating some local medical traditions and addressing specific epidemiological variations.
  • A significant gap remains in integrating country-specific economic and access-related factors into these guidelines.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
246
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
164
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
193
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
612
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
823
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
601